Tg Therapeutics (TGTX) Depreciation & Amortization (CF) (2023 - 2026)
Tg Therapeutics (TGTX) posted quarterly Depreciation & Amortization (CF) of $32000.0 for Q1 2026, up 300.0% year-over-year from $8000.0 in Q1 2025, and up 52.38% quarter-over-quarter from $21000.0 in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Tg Therapeutics' Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $32000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 300.0% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $83000.0 (up 76.6% YoY), while the FY2025 annual figure was $59000.0, down 13.24% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $32000.0, up from $21000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $78000.0 in Q2 2022, with the low at $8000.0 in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $32000.0 (2023), against an average of $39588.2.
- The sharpest annual moves came in 2024 and 2026: Depreciation & Amortization (CF) sank 84.93% in 2024, then soared 300.0% in 2026.
- Tg Therapeutics' Depreciation & Amortization (CF) stood at $73000.0 in 2022, then plunged by 47.95% to $38000.0 in 2023, then sank by 76.32% to $9000.0 in 2024, then soared by 133.33% to $21000.0 in 2025, then jumped by 52.38% to $32000.0 in 2026.
- Business Quant data shows TGTX's Depreciation & Amortization (CF) at $32000.0 in Q1 2026, $21000.0 in Q4 2025, and $17000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 68,000.00 |